Adage Capital Partners Gp, L.L.C. Sutro Biopharma, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$51.6 Billion
Q1 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,000,000 shares of STRO stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,000,000

Previous 2,000,000 -0.0%

Holding current value

$1.6 Million

Previous $3.68 Million 64.67%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.82 - $4.4 $455,240 - $1.1 Million	-250,132 Reduced 11.12%	2,000,000 $3.68 Million
Q3 2024 Nov 14, 2024	BUY	$2.88 - $5.01 $720,380 - $1.25 Million	250,132 Added 12.51%	2,250,132 $7.79 Million
Q1 2024 May 15, 2024	SELL	$3.27 - $5.65 $8.07 Million - $13.9 Million	-2,467,796 Reduced 55.24%	2,000,000 $11.3 Million
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $2.82 Million - $6.19 Million	1,362,664 Added 43.88%	4,467,796 $19.2 Million
Q3 2023 Nov 14, 2023	BUY	$3.29 - $4.9 $9.47 Million - $14.1 Million	2,879,412 Added 1275.66%	3,105,132 $10.8 Million
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $722,500 - $999,600	170,000 Added 305.1%	225,720 $1.05 Million
Q1 2023 May 15, 2023	BUY	$4.48 - $8.45 $249,625 - $470,833	55,720 New	55,720 $257,000
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $1.24 Million - $2.45 Million	-160,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $1.64 Million - $2.71 Million	-115,000 Reduced 41.82%	160,000 $2.38 Million
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $844,000 - $1.12 Million	-50,000 Reduced 15.38%	275,000 $5.2 Million
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $2.26 Million - $2.98 Million	-125,300 Reduced 27.83%	325,000 $6.04 Million
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $501,163 - $680,238	-24,700 Reduced 5.2%	450,300 $10.2 Million
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $2.54 Million - $6 Million	-250,000 Reduced 34.48%	475,000 $10.3 Million
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $2.17 Million - $3.32 Million	300,000 Added 70.59%	725,000 $5.63 Million
Q1 2020 May 15, 2020	BUY	$6.19 - $12.16 $2.48 Million - $4.86 Million	400,000 Added 1600.0%	425,000 $4.34 Million
Q4 2019 Feb 14, 2020	BUY	$8.15 - $11.39 $203,750 - $284,750	25,000 New	25,000 $275,000

Others Institutions Holding STRO

# of Institutions

118

Shares Held

60.5M

Call Options Held

95.8K

Put Options Held

38.5K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $41.7M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Sutro Biopharma, Inc. Transaction History